Cited by 853Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyGlobal Health Care Issues

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Thresholds for the cost–effectiveness of interventions: alternative approaches

Open access

Marseille, Elliot, Larson, Bruce, Kazi, Dhruv S, Kahn, James G, Rosen, Sydney·2015·Bulletin of the World Health Organization

DOI 10.2471/blt.14.138206PMC PMC4339959

Open this paper in CoChat — free account

Abstract

Many countries use the cost-effectiveness thresholds recommended by the World Health Organization's Choosing Interventions that are Cost-Effective project (WHO-CHOICE) when evaluating health interventions. This project sets the threshold for cost-effectiveness as the cost of the intervention per disability-adjusted life-year (DALY) averted less than three times the country's annual gross domestic product (GDP) per capita. Highly cost-effective interventions are defined as meeting a threshold per DALY averted of once the annual GDP per capita. We argue that reliance on these thresholds reduces the value of cost-effectiveness analyses and makes such analyses too blunt to be useful for most decision-making in the field of public health. Use of these thresholds has little theoretical justification, skirts the difficult but necessary ranking of the relative values of locally-applicable interventions and omits any consideration of what is truly affordable. The WHO-CHOICE thresholds set such a low bar for cost-effectiveness that very few interventions with evidence of efficacy can be ruled out. The thresholds have little value in assessing the trade-offs that decision-makers must confront. We present alternative approaches for applying cost-effectiveness criteria to choices in the allocation of health-care resources.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2471/blt.14.138206

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,078
Methods for the economic evaluation of health care programmes
Wilson, S. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,312
Cost-Benefit Analysis: Concepts and Practice
Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (1996) · Cited by 1,920
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Methods for the economic evaluation of health care programmes, 3rd ed
Adamiak, G. T. (2006) · PubMed Central · Cited by 953
The Value of Life and the Rise in Health Spending
Hall, R. E., & Jones, C. I. (2007) · The Quarterly Journal of Economics · doi:10.1162/qjec.122.1.39 · Cited by 924
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G. H., Ioannidis, J. P. A., Thabane, L., Gluud, L. L., Als-Nielsen, B. E. T., & Gluud, C. N. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 834
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819

Flagged first, then by citations

Show all 42 references

Sorted by citations

Items 601–700 of 853

Global health benefits and cost-effectiveness of indoor air purification to mitigate PM2.5 from wildfire smoke
Han, D., Guo, Y., Ji, J. S., Wang, J., & Zhao, B. (2026) · Nature Health · doi:10.1038/s44360-026-00105-1 · Cited by 3
The cost-effectiveness of Wolbachia-based biocontrol interventions for dengue: A scoping review of the available evidence
Turner, H. C., Hung, T. M., Brady, O. J., Velayudhan, R., Dorigatti, I., & Clapham, H. E. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014395 · Cited by 3
Modeling the Scale‐up of Surgical Services for Children with Surgically Treatable Congenital Conditions in Somaliland
Vigliotti, V. S., Concepcion, T. L., Mohamed, M., Dahir, S., Ismail, E. A., Poenaru, D., Rice, H. E., & Smith, E. R. (2022) · World Journal of Surgery · doi:10.1007/s00268-022-06651-5 · Cited by 3
Routine Histopathologic Examination of Bone Obtained During Elective Primary Total Knee Arthroplasty May Not Be Necessary
McNamara, C., Bondar, K. J., Sullivan, T. C., Clyburn, T. A., Park, K. J., & Brown, T. S. (2023) · Arthroplasty Today · doi:10.1016/j.artd.2023.101200 · Cited by 3
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China
He, C., Mi, X., Xu, G., Xu, X., Xin, W., Zhong, L., Zhu, J., Shu, Q., Fang, L., & Ding, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302961 · Cited by 3
Evolution of Health Technology Assessment in Indonesia: Supply Landscape, Implementation, and Future Directions
Hidayat, B. (2023) · Health Systems & Reform · doi:10.1080/23288604.2024.2371470 · Cited by 3
Intensive interdisciplinary specialized rehabilitation or regular physiotherapy for multiple sclerosis? A randomised controlled trial with economic evaluation
Bonnyaud, C., Hameau, S., Zory, R., Sznajder, M., Heinzlef, O., Aymard, C., Chenet, A., Médée, B., Jacota, M., Gallien, P., et al. (2025) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2024.101898 · Cited by 3
Health economic evaluation of a risk-stratified intervention in diabetic kidney disease
Kalhan, T. A., Luo, M., Chai, J. H., Tai, E. S., Lim, S. C., Coffman, T. M., & Venkataraman, K. (2025) · Diabetologia · doi:10.1007/s00125-025-06498-0 · Cited by 4
Cost-effectiveness analysis in primary care research: A practical guide for early-career researchers
Lukwa, A. T., Pressentin, K. B. V., & Mash, R. J. (2025) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v17i2.5163 · Cited by 4
Cost - effectiveness and Cost - utility of CinnoVex versus ReciGen in Patients with Relapsing - Remitting Multiple Sclerosis in Iran
Ravangard, R., Rezaee, M., Keshavarz, K., Borhani‐Haghighi, A., & Izadi, S. (2018) · Shiraz E-Medical Journal · doi:10.5812/semj.67363 · Cited by 3
The cost–effectiveness of low-dose budesonide as a Step 2 treatment for pediatric asthma in China
Wang, X., Fang, H., Shen, K., Liu, T., Xie, J., Liu, Y.-T., Zhong, J., Wu, E. Q., Zhou, W., & Wu, B. Y. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0102 · Cited by 3
Impact of innovative pelvic floor muscle training on quality-adjusted life years (QALYs) in women with stress urinary incontinence treated by duloxetine
Švihra, J., Hagovská, M., Breza, J., Jr., Dubravicky, J., Vargovčák, M., Svihra, J., & Ľupták, J. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.06.025 · Cited by 3
Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis
Kejela, S. (2021) · BMC Medical Imaging · doi:10.1186/s12880-021-00696-z · Cited by 3
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries
Rajasingham, R., Nalintya, E., Israelski, D. M., Meya, D. B., Larson, B. A., & Boulware, D. R. (2022) · Medical Mycology · doi:10.1093/mmy/myab078 · Cited by 3
Self-citation
Cost-effectiveness analysis of seasonal influenza vaccination during pregnancy: A systematic review
Ostad-Ahmadi, Z., Boccalini, S., Daemi, A., & Ahari, A. M. (2023) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2023.102632 · Cited by 3
Health service readiness to provide care for HIV and cardiovascular disease risk factors in low- and middle-income countries
Cockburn, N., Flood, D., Seiglie, J. A., Manne‐Goehler, J., Aryal, K. K., Karki, K. B., Damasceno, A. A. M., Atun, R. A., Vollmer, S., Bärnighausen, T., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002373 · Cited by 3
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes
Abushanab, D., Chbib, S., Kaddoura, R., Hail, M. A., Pallivalapila, A., Elkassem, W., Shah, J. Z., Nair, R. K. R., & Al‐Badriyeh, D. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2322258 · Cited by 3
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data
Griffiths, A. D., Young, R. O., Yuan, Y., Chaudhary, M. A., Lee, A., Gordon, J. P., & McEwan, P. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00545-z · Cited by 3
Towards Human-Centric, Sustainable, and Resilient Robot Technologies
Lauretti, C., di Luzio, F. S., Demofonti, A., Tamantini, C., Cordella, F., Tagliamonte, N. L., & Zollo, L. (2025) · Springer eBooks · doi:10.1007/978-981-96-1437-0_4 · Cited by 3
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013
Brouwer, E., Basu, A., & Yeung, K. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00821-5 · Cited by 3
Surveillance Intensity Comparison by Risk for T1NX Locally Excised Rectal Adenocarcinoma: a Cost-Effective Analysis
McCain, M., O’Neill, Y., Hernandez, H., Foley, R., Sadowski, B. M., Torgersen, Z., Beaty, J. S., Payacan, R. R., & Ternent, C. A. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04369-9 · Cited by 3
A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus–Infected Adults on Antiretroviral Therapy
Grover, G., & Aggarwal, S. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2020.06.002 · Cited by 3
Diagnosis of Prostate Adenocarcinoma on Routine Pathology After a Primary Total Hip Arthroplasty
Kheir, M. M., Bauer, T. W., & Westrich, G. H. (2022) · Arthroplasty Today · doi:10.1016/j.artd.2022.02.025 · Cited by 3
Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento
Trigo, J. A. L., Mongil, R. L., Lázaro, A. M., Chaín, G. M., Villajos, N. M., & Cordero, P. R. (2018) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2018.06.004 · Cited by 3
Should GM Rice with Nutrition Benefits Be Deployed? Findings from Biotech and Socio-Economic Research
Steur, H. D., Blancquaert, D., Stove, C. P., Lambert, W. E., Straeten, D. V. D., & Gellynck, X. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316585269.013 · Cited by 3
Cost‐effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis ( IC ) in Turkey
Neoh, C. F., Şenol, E., Kara, A., Dinleyici, E. Ç., Turner, S. J., & Kong, D. C. M. (2017) · Mycoses · doi:10.1111/myc.12651 · Cited by 3
Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan
Ye, X., Gray, E., Wang, Y.-F., & Wang, S. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1720694 · Cited by 3
A cohort study of two intravenous treatments for iron deficiency in patients with heart failure
Arias-Barrera, C. A., Palacios-Ariza, M. A., Pradilla, I. F., & Álvarez, C. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2019.1639270 · Cited by 3
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India
Kazemian, P., Ding, D. D., Scott, J. A., Feser, M. K., Biello, K. B., Thomas, B. E., Dange, A., Bedoya, C. A., Balu, V., Rawat, S. M., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003231 · Cited by 3
Measles vaccination of young infants in China: A cost-effectiveness analysis
Janusz, C. B., Wagner, A. L., Masters, N. B., Ding, Y., Zhang, Y., Hutton, D. W., & Boulton, M. L. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.079 · Cited by 3
Response to proposal for a novel cancer drug pricing model
van der Gronde, T., Leufkens, H. G. M., & Pieters, T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0062-7 · Cited by 3
Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific
Bilgin, G. M., Munira, S. L., Lokuge, K., & Glass, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294091 · Cited by 2
Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina
Grujić-Vujmilović, D., Veljković, K., Gavrić, Ž., & Popović-Pejičić, S. (2024) · Libyan Journal of Medicine · doi:10.1080/19932820.2024.2437226 · Cited by 2
Clear Waters, Bright Futures: Do Low‐Cost Information Interventions Increase Health Preventive Behaviors
Amir‐ud‐Din, R., Khan, M. A., Murad, Z., & Mussio, I. (2025) · Health Economics · doi:10.1002/hec.4977 · Cited by 2
Cost-effectiveness of specialized trauma care: A systematic review
Gnanou, S., Guertin, J. R., Tardif, P., Conombo, B., Berube, M., Yanchar, N. L., Berthelot, S., Gnanvi, J., & Moore, L. (2025) · Journal of Health Services Research & Policy · doi:10.1177/13558196251348409 · Cited by 2
Inappropriate comparator and high pricing in MDMA-assisted therapy for PTSD: A critique of the Lykos cost-effectiveness analysis
Marseille, E. A., & Mitchell, J. (2025) · Psychedelics · doi:10.1016/j.psyche.2025.100002 · Cited by 2
Self-citation
Economic evaluation of financial incentives for maternal and child health in the Democratic Republic of the Congo (DRC): a decision-tree modelling based on a cluster randomized controlled trial
Zeng, W., Shapira, G., Gao, T., Muvudi, M., Li, G., Bouey, J., Antwisi, D., & Yamani, F. E. K. E. (2025) · Global Health Research and Policy · doi:10.1186/s41256-025-00435-9 · Cited by 2
The cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer
Yang, P., Pei, Z., Zhou, Y., & Pei, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-28263-4 · Cited by 2
Effectiveness and Cost-Effectiveness of an App-Based Mindfulness Breast Care Program for Reducing Body Image Distress and Stigma Among Survivors of Breast Cancer: Randomized Controlled Trial
Lin, H., Zhong, Y., Zheng, S., Jiang, X., Xu, Y., Chan, S., Liu, S., Chow, K. M., Yang, Q., Huang, W., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/85913 · Cited by 2
Recomendações multidisciplinares portuguesas sobre o pedido de DXA e indicação de tratamento de prevenção das fraturas de fragilidade
Marques, A., Rodrigues, A. M., (SPR), E. R. D. S. P. D. R., Romeu, J. C., Ruano, A., (SPOT), E. R. D. S. P. D. O. E. D. T., Barbosa, A. P., (SPODOM), E. R. D. S. P. D. O. E. D. Ó. M., Eugenia, V., (SPODOM), E. R. D. S. P. D. O. E. D. Ó. M., et al. (2016) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v32i6.11964 · Cited by 29
Universal HPV Vaccination – a Global Prerogative
Prue, G., Graham, D. M., Shapiro, G. K., Santin, O., Banks, I., & Lawler, M. (2018) · International Journal of Men s Social and Community Health · doi:10.22374/ijmsch.v1isp1.7 · Cited by 2
Valuing Health: Evolution, Revolution, Resistance, and Reform
Phelps, C. E., & Madhavan, G. (2019) · Value in Health · doi:10.1016/j.jval.2019.01.010 · Cited by 2
Cost Utility of Supporting Family-Based Care to Prevent HIV and Deaths among Orphaned and Separated Children in East Africa: A Markov Model–Based Simulation
Wilson-Barthes, M. G., Braitstein, P. K. A., DeLong, A. K., Ayuku, D., Atwoli, L., Sang, E., & Galárraga, O. (2022) · MDM Policy & Practice · doi:10.1177/23814683221143782 · Cited by 2
Cost‐effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial
Singh, K., Kondal, D., Menon, V. U., Varthakavi, P. K., Viswanathan, V., Dharmalingam, M., Bantwal, G., Sahay, R. K., Masood, M. Q., Khadgawat, R., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15074 · Cited by 2
Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in Mozambique
Corlis, J., Zhu, J., Macul, H., Tiberi, O., Boothe, M., & Resch, S. (2023) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-023-00474-4 · Cited by 2
Measuring the cost‐effectiveness of treating rectovaginal and vesicovaginal fistulas: A multicenter global study by the Fistula Foundation
Rajagopal, K., Pollaczek, L., Chu, J., & Mann, H. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15502 · Cited by 2
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit
Alhersh, E., Abushanab, D., Abounahia, F. F., Rainkie, D. C., Hail, M. A., Abdulrouf, P. V., Elkassem, W., & Al‐Badriyeh, D. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2345218 · Cited by 2
Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study
Sen, S., Braunack-Mayer, L., Kelly, S. L., Masserey, T., Malinga, J., Moehrle, J. J., & Penny, M. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-93623-z · Cited by 2
How to Assess Health Gains
Guarducci, G., Messina, G., Siragusa, C., Gurnari, J., Gentile, A. M., & Nante, N. (2025) · Healthcare · doi:10.3390/healthcare13070832 · Cited by 2
World Health Organization의 비용효과 권고역치에 대한 비판적 탐색
양봉민 (2015) · The Journal of Health Technology Assessment · doi:10.34161/johta.2015.3.2.001 · Cited by 2
Knowledge, Attitudes, and Behavior of Larva Monitoring Interpreter (Jumantik) Cadre as Efforts to Prevent Dengue Cases
Djaafar, T., Syam, D. M., Bungawati, A., & Arianty, R. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8453 · Cited by 2
Cost-Effectiveness Analysis of Two Chemotherapy Regiments FAC vs. Taxane for Operable Breast Cancer Patients in Indonesia
Saptaningsih, A. B., Nikmah, U. S., Aryandono, T., Dwiprahasto, I., & Thobari, J. A. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.4.1147 · Cited by 2
Cost-effectiveness of Obesity Interventions: Will We Know It When We See It?
Finkelstein, E. A. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1916 · Cited by 2
Comparative pharmacoeconomic evaluation of the treatment of type 2 diabetes mellitus with insulin degludec and insulin glargine in basal-bolus insulin therapy
Колбин, А. С., Shestakova, M. V., Galstyan, G. R., Zhao, W., Mosikian, A. A., Kurylev, A. A., Balykina, Y. Е., Proskurin, M. A., Alekseeva, Y. G., & Startseva, E. (2017) · Problems of Endocrinology · doi:10.14341/probl2017635307-319 · Cited by 1
The Clinical and Ethical Practice of Neuromodulation – Deep Brain Stimulation and Beyond
Christen, M., & Müller, S. (2018) · Frontiers research topics · doi:10.3389/978-2-88945-373-3 · Cited by 2
An Attempt to Quantitate “Value” In Medical Oncologic Therapy
Hancock, C., Green, L., Lestingi, T. M., & Bitran, J. D. (2018) · Cureus · doi:10.7759/cureus.2810 · Cited by 2
The Elderly in Intensive Care
Reece, G., & Poojara, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-96998-5_14 · Cited by 2
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck Cancer
Rognoni, C., Quaglini, S., Vermorken, J. B., Cecco, L. D., Licitra, L. F., & Bossi, P. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.09.015 · Cited by 2
The economic theory of cost‐effectiveness thresholds in health: Domestic and international implications
Moradpour, J., & Hollis, A. (2021) · Health Economics · doi:10.1002/hec.4247 · Cited by 2
Cost-Effectiveness Analysis of Group vs. Weblog Telecommunication (Web Tel) Nutrition Education Program on Glycemic Indices in Patients With Non-Insulin Dependent Diabetes Mellitus Type 2: A Randomized Controlled Trial
Derakhshandeh‐Rishehri, S., Keshavarz, K., Ghodsi, D., Pishdad, G., & Faghih, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.915847 · Cited by 2
Cost-effectiveness of postoperative imaging surveillance strategies for nonfunctional pituitary adenomas after resection with curative intent
Caulley, L., Dijk, S. W., Krijkamp, E., Dong, S. X., Alkherayf, F. A., Amrani, L., Doyle, M.-A., Eid, A. A., Johnson‐Obaseki, S., Khoury, M., et al. (2023) · Journal of neurosurgery · doi:10.3171/2023.2.jns221903 · Cited by 2
Africa region: Ghana
Tannor, A. Y., Nyarko, F. K. A., Quao, B. O., & Ebenezer, A. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91931-9.00003-7 · Cited by 2
Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers
Basu, A., Dutta, A. K., Bagepally, B. S., Das, S., Cherian, J. J., Roy, S., Maurya, P. K., Saha, I., Sukumaran, D., Rina, K., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300511 · Cited by 2
EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS
Frolov, M. Y., & Rogov, V. A. (2017) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909.2017.10.1.003-010 · Cited by 2
The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C
Alowairdhi, M. A., Vaidya, V., Sahloff, E. G., & Puffer, C. (2020) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2020.04.0579 · Cited by 2
The Two-Year Outcomes and Cost Effectiveness of a Commercial Weight Loss Program for the Prevention of Type 2 Diabetes among People with Prediabetes
Palmer, K. N. B., Saha, C., Phillips, E. O., Krishnan, A., Foster, G. D., Finkelstein, E. A., Wojtanowski, A. C., & Marrero, D. G. (2018) · Endocrinology Diabetes and Obesity · doi:10.31532/endocrinoldiabetesobes.1.1.005 · Cited by 2
Warum findet die Wirtschaftsethik in der Krise kaum Gehör? Die normativen Grenzen der ökonomischen Theorie im Pandemie-Diskurs
Althammer, J., & Nass, E. (2020) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783748909460-35 · Cited by 2
Cost-Effectiveness of Ticagrelor for Acute Coronary Disease to Prevent Cardiovascular Events in Three Hospitals in Indonesia
Thobari, J. A., Krisdinarti, L., Nugroho, D., Haposan, J. H., Firdaus, I., Suryandani, R. A. R., Munawar, M., & Agung, J. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9671 · Cited by 3
Health technology assessment of hyperphosphatemia management among hemodialysis patients in Lebanon
Rizk (2017) · doi:10.26481/dis.20170622rr · Cited by 2
Economic evaluation of disease elimination: an extension to the net-benefit framework and application to human African trypanosomiasisPreprint
Antillón, M., Huang, C.-I., Rock, K. S., & Tediosi, F. (2021) · medRxiv · doi:10.1101/2021.02.10.20181974 · Cited by 2
An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics
Snyder, C. M., Hoyt, K., & Gouglas, D. (2022) · National Bureau of Economic Research · doi:10.3386/w30619 · Cited by 2
A Cost-Benefit Analysis of Selected Digital Projects in Latin America and the Caribbean
Cristia, J., Bernal, P., Santamaría, J., Algarra, P., Bernal, C., Escalante, L., Gallegos, A., Irazoque, N., Ortiz, E. A., Gambi, G. D. N., et al. (2022) · doi:10.18235/0004525 · Cited by 4
Addressing prevention and management of wasting and nutritional oedema in children requires an improved evidence base on resource use and cost-effectiveness of interventions
Huybregts, L., Berkley, J. A., Castro, M. C., Dewey, K. G., Golden, K., Jemutai, J., Naude, C. E., McCaul, M., & Daniel, A. I. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016220 · Cited by 2
Limiar de eficiência em avaliações de tecnologias em saúde
Saad, R., Lemmer, T., & Clark, O. A. C. (2017) · Jornal Brasileiro de Economia da Saúde · doi:10.21115/jbes.v9.suppl1.115-122 · Cited by 1
Evaluating Alternative Designs of a Multilevel HIV Intervention in Maharashtra, India: The Impact of Stakeholder Constraints
Patel, A. R., Ruggles, K. V., Nucifora, K. A., Zhou, Q., Schensul, S. L., Schensul, J. J., BRYANT, K. J., & Braithwaite, R. S. (2018) · MDM Policy & Practice · doi:10.1177/2381468318803940 · Cited by 1
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy
Mantovani, L. G., Cortesi, P. A., Cardillo, A., Santoni, L., & Prosperini, L. (2022) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v23i1.1510 · Cited by 1
Cost benefit analysis of alternative testing and quarantine policies for travelers for infection control: A case study of Singapore during the COVID-19 pandemic
Lou, J., Lim, N. W.-H., Cai, C. G. X., Dickens, B. S. L., Huynh, V. A., & Wee, H. L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1101986 · Cited by 1
A RELAÇÃO CUSTO/EFETIVIDADE DE EXAMES DE IMAGEM COMO PARÂMETRO DE EFICIÊNCIA EM UM SERVIÇO DE SAÚDE NO DIAGNÓSTICO DA PNEUMONIA COMUNITÁRIA ADQUIRIDA
Nunes, N. B., & Pacheco, M. A. B. (2023) · Saúde Coletiva (Barueri) · doi:10.36489/saudecoletiva.2023v13i86p12537-12560 · Cited by 1
Cost-Effectiveness Analysis of E-cigarettes Compared to Nicotine Replacement Therapy for Smoking Cessation Among Medicaid Users in California
Chen, A. W., & Fishman, P. A. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae219 · Cited by 1
Rare Oncological Diseases and Their Large Slice in Demands to the Brazilian Government for Health Technologies Over 12 Years Since the Creation of CONITEC
de Andrade, R. G., Nunes, A. A., & Cazarim, M. D. S. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2024.101072 · Cited by 1
Cost effectiveness analysis of expanding tuberculosis preventive therapy to household contacts aged 5–14 years in the Philippines
Ilaiwy, G., Keim‐Malpass, J., Tuppal, R. M., Ritua, A. F., Bassiag, F. R., & Thomas, T. A. (2025) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2025.100519 · Cited by 1
Cost-effectiveness of colorectal cancer screening under different scenarios of colonoscopy adherence: a microsimulation study
Wu, W.-X., Yang, J., Tan, Y., Gu, K., Shen, Q., Chen, Y., Hu, M., Xiang, Y., & Xu, W. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001344 · Cited by 1
Chronic kidney disease screening in Iran: a cost-effectiveness analysis of different strategies
Keshvari-Shad, F., Yousefi, M., Ebrahimi, S. H., Ahari, A. M., Nemati, N., & Rezaei, S. (2025) · Renal Replacement Therapy · doi:10.1186/s41100-025-00645-4 · Cited by 1
Value for health: how fortified infant cereals provide cost-effective solutions to iron deficiency anaemia in Egypt
Elmrayed, S. A., Mottaz, S. C., Dainelli, L., Salib, H., Ghaffar, H. A., & Gendy, Y. G. E. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1570683 · Cited by 1
Dominance-Based Distributional Cost-Effectiveness Analysis of Cardiovascular Disease Risk Screening in Sri Lanka
Wijemunige, N., van Baal, P. H. M., Rannan-Eliya, R. P., & O’Donnell, O. (2025) · Value in Health · doi:10.1016/j.jval.2025.09.3062 · Cited by 1
Cost-utility analysis of screening and cognitive behavioral therapy compared to usual care for postpartum depression
Wang, B., Shen, S., Lok, K. Y. W., Lin, J., & Smith, R. D. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07459-y · Cited by 2
Economic Burden and Cost-Effectiveness of Cancer Care in Ethiopia: A Systematic Review
Tarekegn, T. B., Ashagrie, G., Kassaw, A. T., Gebrie, D., & Girmaw, F. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101515 · Cited by 1
Cost-Effectiveness Analysis and Priority Setting in the Transition from Iron-Folic Acid (IFA) to Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Indonesia
Alfiani, F., Utami, A., Zakiyah, N., Daud, N. A. A., Suwantika, A. A., & Puspitasari, I. M. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s549589 · Cited by 2
Economic burden of Sanfilippo syndrome in the United States
Ashby, F. J., Park, H., Svensson, M., & Heldermon, C. D. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01733-x · Cited by 1
Cost-effectiveness and budget impact analyses of Typhoid Vi capsular polysaccharide vaccination in Indonesia
Sandy, P. M., Purba, F. D., & Suwantika, A. A. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e143516 · Cited by 1
Population-level assessment of healthcare cost-effectiveness from the payer’s perspective in the Czech Republic: methodology and threshold setting using administrative data
Fojtíková, M., & Fiala, J. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2025.2609503 · Cited by 1
Cost-Effectiveness of Anticoagulation Treatment for Subclinical Device-Detected Atrial Fibrillation
Winstén, A. K., Langén, V. L., Airaksinen, K. E. J., & Teppo, K. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.17213 · Cited by 1
Innovation, cost, and evidence: a critical appraisal of robotic surgery in head and neck and endocrine surgery
Dave, J., Rajguru, R., Chanda, S., Saikia, R., & Sood, R. (2026) · Journal of Robotic Surgery · doi:10.1007/s11701-026-03802-x · Cited by 1
Экономика скрининга рака шейки матки. Вчера, сегодня, завтра. Часть 1
Zarochentseva, N. V., Константиновна, Д. Л., & И., Б. А. (2025) · Medical Opponent · doi:10.64831/2619-0001.2025.3.314751 · Cited by 1
Cost-effectiveness of dengue vaccination in Brazil
Durand, L., Genovez, V., & Araújo, D. V. (2017) · Jornal Brasileiro de Economia da Saúde · doi:10.21115/jbes.v9.n1.p12-29 · Cited by 1
Improving the Efficiency of the HIV/AIDS Policy Response: A Guide to Resource Allocation Modeling
Kahn, J. G., Bollinger, L. A., Stover, J., & Marseille, E. A. (2017) · Europe PMC (PubMed Central) · doi:10.1596/978-1-4648-0524-0/ch9 · Cited by 1
Self-citation
Combining econometric analysis and simulation modeling to evaluate Population-Based health policies for chronic disease prevention and control
Xie, X., Fan, Z., Li, Y., Kang, J., & Zhang, D. “. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101586 · Cited by 1
Forecasting the Health Burden of NCDs in Saudi Arabia
Bruckner, T. A., Lee, E., Alqunaibet, A., Finkelstein, E. A., Herbst, C. H., & Almudarra, S. (2021) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-1717-5_ch3 · Cited by 1
Interest in and Uptake of Postabortion Long-Acting Reversible Contraception After Counseling at a Free-Standing Abortion Care Ambulatory Surgery Center, Atlanta, Georgia, 2017‒2018
Wall, K. M., Phillips, V., Xue, A., Cordes, S., Riley, H. E. M., Anderson, E. J., Dickey, M. S., & Haddad, L. B. (2022) · American Journal of Public Health · doi:10.2105/ajph.2022.306940 · Cited by 1
Cost‐effectiveness of zinc interventions in China: A cohort‐based Markov model
Tan, F., Wang, J., Guo, Y., Deng, T., Steur, H. D., & Fan, S. (2023) · Agribusiness · doi:10.1002/agr.21861 · Cited by 1

Authors: Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S.
Affiliations: Health Strategies International, 555 Fifty-ninth Street, Oakland, California, 94609, United States of America (USA).
Boston University (US)
San Francisco General Hospital (US)
University of California, San Francisco (US)
Corresponding author: Marseille, Elliot
ORCID: Marseille, Elliot
Larson, Bruce
Kazi, Dhruv S
Kahn, James G
Rosen, Sydney
Venue: Bulletin of the World Health Organization
Publisher: WHO Press
Published: 2014-12-15
Volume: 93
Issue: 2
Pages: 118-124
ISSN: 0042-9686 (ISSN-L)
DOI: 10.2471/blt.14.138206
PMC: PMC4339959
OpenAlex: W2133104890
Cited by: 851
References: 42
Citations by year: 2026: 45 · 2025: 68 · 2024: 58 · 2023: 69 · 2022: 93 · 2021: 101 · 2020: 100 · 2019: 105 · 2018: 76 · 2017: 78 · 2016: 40 · 2015: 18
FWCI: 112.73
Type: journal article
Language: en
Open access: diamond
doi.org
Licence: cc-by
Locations: Bulletin of the World Health Organization (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Mental Health (P30MH062246)
National Institute on Drug Abuse (R01DA015612)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
Keywords: cost-effectiveness threshold, WHO-CHOICE, disability-adjusted life years, GDP per capita, healthcare resource allocation, public health decision-making, affordability, cost-effectiveness analysis
MeSH terms: Cost-Benefit Analysis, Developing Countries, Female, Health Priorities, Humans, Pregnancy, Syphilis, Global Health, World Health Organization, HIV Infections, Quality-Adjusted Life Years, Benchmarking, Anti-Retroviral Agents, Insecticide-Treated Bednets, Gross Domestic Product

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Thresholds for the cost–effectiveness of interventions: alternative approaches

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks